We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VPT market cap is 36.07M. The company's latest EPS is CAD -0.0311 and P/E is -7.40.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 66k | 176k | 270k | 0 | 68k |
| Operating Income | -3.82M | -3.23M | -1.65M | -3.72M | -4.91M |
| Net Income | -2.08M | -3.32M | -1.85M | -3.88M | -4.87M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 466k | 314k | 802k | 9.54M | 5.98M |
| Total Liabilities | 1.44M | 2.78M | 3.15M | 1.21M | 1.42M |
| Total Equity | -973k | -2.47M | -2.35M | 8.33M | 4.55M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.05M | -2.38M | -1.1M | -3.15M | -4.14M |
| Investing | -27k | -17k | -4k | -4k | N/A |
| Financing | 1.84M | 2.35M | 1.62M | 11.89M | 87k |
| Market Cap | 36.07M |
| Price to Earnings Ratio | -7.40 |
| Price to Sales Ratio | 575 |
| Price to Cash Ratio | 6.95 |
| Price to Book Ratio | 7.92 |
| Dividend Yield | - |
| Shares Outstanding | 156.82M |
| Average Volume (1 week) | 46.04k |
| Average Volume (1 Month) | 91.02k |
| 52 Week Change | 39.39% |
| 52 Week High | 0.36 |
| 52 Week Low | 0.13 |
| Spread (Intraday) | 0.02 (6.12%) |
| Company Name | Ventripoint Diagnostics Ltd |
| Address |
suite 605, 2 sheppard avenue east toronto, ontario M2N 5Y7 |
| Website | https://www.ventripoint.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
